ACTRN12609000226202已完成未知
An observational, multicentre, open label non interventional programme to assess the long-term safety and efficacy of Somatuline (registered trade mark) Autogel (registered trade mark) in the treatment of neuroendocrine tumours when administered by patients or their partners (Home Injection Group) or administered by healthcare professionals.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients on a stable dose of Somatuline Autogel for at least 4 months and with a diagnosis of Neuroendocrine tumours.
排除标准
- •Patients who are pregnant or breastfeeding.
研究者
相似试验
已完成
不适用
Observational study comparing the safety and tolerability of Somatuline (Registered trade mark) Autogel (Registered trade mark) injected by Health Care Professionals and patients who inject at home for the treatment of acromegaly.Metabolic and Endocrine - Other metabolic disordersAcromegalyACTRN12608000606381Ipsen Pty Ltd38
已完成
4 期
A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India (Lead-In)CTRI/2010/091/001280ovo Nordisk India Private Ltd1,386
招募中
4 期
Study to assess effectiveness of indacaterol in COPD patients in real life settingsCTRI/2013/09/004004ovartis Healthcare Private Limited4,500
已完成
4 期
observational study in patients with hypertensioCTRI/2018/03/012787Dr Reddys Laboratories Ltd500
已完成
4 期
observational study in patients with blood pressureCTRI/2018/02/011727Dr Reddys Laboratories Ltd600